calicivirida
human
nonhuman
pathogen
virus
high
divers
member
calicivirida
ie
human
pathogen
noroviru
rabbit
hemorrhag
diseas
viru
rhdv
worldwid
emerg
pathogen
noroviru
major
caus
viral
gastroenter
worldwid
account
outbreak
europ
unit
state
million
case
infect
report
year
sinc
emerg
agent
fatal
hemorrhag
diseas
rabbit
rhdv
kill
million
rabbit
dispers
inhabit
contin
view
success
appar
increas
emerg
develop
antivir
strategi
control
infect
due
viral
pathogen
becom
import
issu
medicin
veterinari
medicin
antivir
strategi
base
understand
epidemiolog
transmiss
clinic
symptom
viral
replic
immun
infect
result
infect
virus
provid
overview
mechan
underli
caliciviru
infect
focus
molecular
aspect
replic
host
cell
recent
experiment
data
gener
intern
collabor
structur
biolog
virolog
drug
design
within
european
consortium
vizier
also
present
base
analysi
propos
antivir
strategi
may
significantli
impact
epidemiolog
characterist
highli
success
viral
pathogen
famili
calicivirida
includ
virus
caus
broad
spectrum
diseas
wide
varieti
mammalian
avian
marin
anim
may
rang
acut
gastroenter
human
noroviru
sapoviru
lethal
enceph
immun
defici
mice
murin
noroviru
haemorrhag
diseas
rabbit
upper
airway
infect
cat
felin
caliciviru
although
calicivirus
infect
human
nonhuman
thu
far
evid
zoonot
caliciviru
reservoir
calicivirus
cv
small
round
virus
rang
nm
diamet
smallest
anim
pathogen
virus
origin
refer
srsv
small
round
structur
virus
surfac
display
cuplik
structur
name
caliciviru
deriv
calyx
cup
fig
clark
lambden
green
cuplik
surfac
virion
capsid
protein
consist
monom
known
virion
protein
contain
two
domain
shell
protrud
p
domain
subdivid
subdomain
chen
et
al
green
subdomain
locat
extern
part
capsomer
radiat
virion
surfac
creat
cuplik
shape
structur
comparison
capsid
protein
reveal
genusspecif
within
subdomain
subdomain
determin
viral
antigen
attach
virion
cellular
receptor
chakravarti
et
al
viral
capsid
play
import
role
resist
virion
environment
chang
resist
high
concentr
chlorin
mgl
residu
concentr
mgl
keswick
et
al
concentr
significantli
reduc
infect
viral
agent
gastroenter
ie
polioviru
rotaviru
addit
viral
capsid
confer
high
resist
physicochem
agent
heat
c
min
acid
ph
h
room
temperatur
organ
solvent
ether
c
h
physicochem
properti
contribut
significantli
highli
contagi
natur
virus
classif
calicivirida
reli
larg
phylogenet
analysi
structur
nonstructur
viral
gene
mainli
due
lack
cell
cultur
system
cultiv
virus
thu
enabl
serolog
test
perform
calicivirida
compris
four
accept
two
tent
genera
includ
human
nonhuman
pathogen
virus
fauquet
et
al
green
green
et
al
mayo
nonhuman
pathogen
virus
cluster
exclus
accept
genera
vesiviru
lagoviru
tent
genera
beconaboviru
recoviru
wherea
genera
noroviru
sapoviru
includ
human
nonhuman
pathogen
phylogenet
analysi
base
complet
sequenc
show
norovirus
cluster
tightli
five
genogroup
human
pathogen
noroviru
belong
genogroup
g
ii
iv
genogroup
ii
contain
far
genotyp
respect
zheng
et
al
nonhuman
pathogen
strain
belong
noroviru
giii
v
oliv
et
al
oliv
et
al
b
park
et
al
genogroup
ii
also
contain
bovin
porcin
norovirus
mauroy
et
al
wang
et
al
wang
et
al
zheng
et
al
genogroup
iv
contain
felin
lion
canin
norovirus
martella
et
al
martella
et
al
genogroup
v
contain
murin
norovirus
mnv
mnv
readili
propag
murin
macrophag
cell
well
murin
cell
variou
murin
cell
line
cox
et
al
henderson
muller
et
al
mumphrey
et
al
thackray
et
al
wobu
et
al
henc
mnv
interest
surrog
pathogen
multipl
cycl
immun
studi
may
also
reflect
properti
norovirus
infect
mice
usual
asymptomat
howev
immun
defici
mice
ie
mnv
type
induc
lethal
enceph
hsu
et
al
karst
et
al
mumphrey
et
al
human
pathogen
noroviru
hunv
major
caus
human
viral
gastroenter
wilhelmi
et
al
foodborn
nonbacteri
gastroenter
lindqvist
et
al
lopman
et
al
worldwid
virus
highli
contagi
teuni
et
al
caus
selflimit
gastroenter
higher
preval
winter
time
age
group
excret
week
infect
asymptomat
patient
kirkwood
streitberg
murata
et
al
siebenga
et
al
genu
sapoviru
contain
five
genogroup
human
pathogen
strain
belong
sapoviru
gi
ii
iv
v
farka
et
al
gallimor
et
al
hansman
et
al
numata
et
al
schuffeneck
et
al
wherea
nonhuman
pathogen
strain
belong
giii
fauquet
et
al
green
et
al
guo
et
al
human
pathogen
sapovirus
distribut
global
caus
viral
gastroenter
age
group
gallimor
et
al
humphrey
et
al
johansson
et
al
lopman
et
al
nakata
et
al
sakuma
et
al
includ
outbreak
hospit
johansson
et
al
simor
et
al
child
day
care
center
matson
et
al
elderli
person
home
humphrey
et
al
major
human
pathogen
sapoviru
strain
belong
gi
gii
virus
genu
lagoviru
caus
agent
hemorrhag
diseas
hepat
european
rabbit
oryctolagu
cuniculu
caus
rabbit
haemorrhag
diseas
antigen
relat
distinct
viru
infect
european
hare
caus
brown
hare
syndrom
laurent
et
al
nonpathogen
strain
design
rabbit
caliciviru
isol
capucci
et
al
also
compel
evid
circul
nonpathogen
strain
either
emerg
origin
ancestr
lineag
recogn
virul
extant
virus
moss
et
al
still
circul
wild
rabbit
wide
diverg
nonpathogen
virus
forrest
et
al
nonpathogen
strain
aros
variant
virul
viru
forrest
et
al
genu
vesiviru
includ
virus
infect
broad
varieti
anim
includ
felin
reptil
amphibian
fish
even
nematod
matson
et
al
smith
boyt
smith
et
al
prototyp
genu
vesicular
exanthema
swine
viru
vesv
display
sequenc
homolog
san
miguel
sea
lion
viru
smsv
neill
et
al
smith
et
al
felin
caliciviru
fcv
import
veterinari
viru
infect
domest
wild
cat
speci
caus
rhiniti
ulcer
diseas
upper
airway
radford
et
al
system
infect
fcv
also
describ
foley
et
al
hurley
et
al
pedersen
et
al
recent
recogn
tent
genera
beconaboviru
recoviru
includ
virus
infect
bovin
nonhuman
primat
respect
fig
becoviru
bovin
enter
caliciviru
naboviru
newburi
nb
nebraska
isol
calf
faec
oliv
et
al
park
et
al
simmond
et
al
smiley
et
al
tulan
viru
isol
faec
rhesu
macaqu
time
recogn
viru
genu
recoviru
rhesu
enter
caliciviru
farka
et
al
calicivirida
genom
consist
singl
strand
positivesens
polyadenyl
rna
molecul
averag
nucleotid
length
contain
either
two
three
open
read
frame
depend
particular
genu
fig
terminu
genom
socal
virion
protein
genomelink
vpg
link
viral
rna
encod
nonstructur
ns
protein
present
calicivirida
follow
order
ntermin
protein
unknown
function
ntpase
small
protein
kda
vpg
viral
proteas
viral
rnadepend
rna
polymeras
rdrp
genera
sapoviru
lagoviru
tent
genera
beconaboviru
encod
within
wherea
encod
separ
genera
noroviru
vesiviru
recoviru
genom
encod
structur
virion
protein
follow
untransl
region
poli
tail
sinc
share
similar
picornavirus
nomenclatur
nonstructur
protein
calicivirida
base
picornavirus
viral
polymeras
call
viral
proteas
vpg
protein
increas
knowledg
caliciviru
replic
genom
organ
last
year
led
new
nomenclatur
viral
structur
protein
design
ntermin
protein
ntpase
vpg
proteas
rnadepend
rna
polymeras
rdrp
structur
protein
design
sapoviru
gi
iv
v
addit
orf
encod
put
small
basic
protein
describ
clark
lambden
hansman
et
al
multipl
cycl
calicivirida
remain
poorli
understood
mainli
limit
possibl
viru
cultiv
inde
among
six
caliciviru
genera
felin
caliciviru
murin
noroviru
easili
propag
cell
system
nonhuman
pathogen
human
pathogen
virus
suitabl
vitro
cultur
system
recent
human
noroviru
isol
viral
rna
propag
five
sequenti
passag
small
epitheli
cell
cultiv
suspens
straub
et
al
remain
unclear
whether
system
suitabl
isol
variou
noroviru
genotyp
anoth
approach
studi
molecular
biolog
caliciviru
replic
make
use
replicon
system
norwalklik
viru
asanaka
et
al
chang
et
al
porcin
enter
caliciviru
also
revers
genet
system
murin
noroviru
chaudhri
et
al
ward
et
al
felin
caliciviru
sosnovtsev
et
al
thumfart
meyer
tulan
viru
farka
et
al
system
provid
futur
opportun
compar
analysi
multipl
cycl
differ
genera
classif
calicivirida
phylogenet
analysi
strain
belong
far
defin
genera
noroviru
sapoviru
lagoviru
vesiviru
two
tent
genera
beconaboviru
recoviru
indic
complet
capsid
sequenc
strain
align
clustal
x
gibson
et
al
phylogenet
analysi
perform
neighbourjoin
method
use
paup
swofford
fcv
use
past
two
decad
surrog
investig
replic
strategi
calicivirida
mani
studi
brought
insight
replic
vesiviru
genom
green
sosnovtsev
et
al
sosnovtsev
et
al
sosnovtsev
et
al
sosnovtseva
et
al
late
addit
knowledg
obtain
studi
murin
noroviru
murin
macrophag
vitro
wobu
et
al
wobu
et
al
calicivirus
display
term
genom
structur
replic
follow
common
characterist
nake
genom
length
rna
infecti
per
se
posit
strand
rna
link
vpg
terminu
bear
poli
tail
terminu
encod
polyprotein
process
cotransl
viral
proteas
lead
least
nonstructur
protein
involv
replic
viral
genom
viral
rdrp
vpg
play
essenti
role
transcript
replic
genom
antigenom
rna
subgenom
rna
vpg
act
caplik
structur
interact
initi
factor
goodfellow
et
al
daughenbaugh
et
al
norovirus
vesivirus
possibl
recovirus
structur
protein
encod
subgenom
rna
sapovirus
lagovirus
possibl
beconabovirus
releas
polyprotein
precursor
cleavag
viral
proteas
small
basic
protein
essenti
virion
gener
sosnovtsev
et
al
schemat
replic
calicivirus
thought
contain
eight
step
fig
attach
viral
capsid
cellular
receptor
virion
intern
rna
genom
packag
endocyt
vesicl
vpg
link
genom
interact
cellular
translat
machineri
eukaryot
initi
factor
complex
ribosom
subunit
daughenbaugh
et
al
daughenbaugh
et
al
translat
polyprotein
cotransl
process
releas
nonstructur
protein
precursor
importantli
proteasepolymeras
precursor
propol
proteas
pro
rnadepend
rna
polymeras
pol
put
ntpase
ntpase
vpg
protein
protein
put
involv
enzymat
complex
replic
genom
synthes
antigenom
rna
antigenom
rna
templat
subgenom
rna
peculiar
calicivirus
norovirus
vesivirus
transcript
subgenom
rna
yield
high
amount
structur
protein
fcv
addit
cleav
viral
proteas
releas
leader
protein
lc
leader
capsid
protein
capsid
matsuura
et
al
sosnovtsev
et
al
sapovirus
lagovirus
beconabovirus
releas
polyprotein
precursor
process
viral
proteas
experiment
data
felin
caliciviru
describ
terminationreiniti
mechan
translat
et
al
mechan
involv
socal
termin
upstream
ribosom
bind
site
turb
may
regul
ratio
product
replic
luttermann
meyer
similar
mechan
terminationreiniti
recent
report
murin
noroviru
napthin
et
al
resembl
terminationiniti
mechan
observ
virus
ie
influenza
viru
antigenom
rna
also
templat
genom
rna
subsequ
translat
matur
nonstructur
protein
given
time
point
multipl
cycl
packag
genom
rna
occur
follow
releas
matur
virion
cell
follow
section
focu
epidemiolog
transmiss
human
pathogen
calicivirus
hucv
noroviru
sapoviru
sinc
virus
prime
interest
antivir
develop
hucv
one
common
caus
acut
gastroenter
worldwid
infect
children
adult
recent
report
cdc
outbreak
occur
usa
noroviru
infect
recogn
common
caus
viral
gastroenter
age
us
account
outbreak
lynch
et
al
widdowson
et
al
major
outbreak
caus
strain
belong
koopman
suggest
genogroup
display
preferenti
featur
term
infect
andor
transmiss
effici
altern
could
reflect
increas
virul
enhanc
activ
viral
enzym
shutoff
cellular
host
factor
cours
infect
anoth
import
aspect
relat
dynam
emerg
norovirus
correl
tightli
propens
diseas
dissemin
commun
time
new
strain
emerg
mutat
andor
recombin
mainli
support
emerg
circul
noroviru
sapoviru
recombin
strain
jiang
et
al
katayama
et
al
phan
et
al
reuter
et
al
rohayem
et
al
vinj
et
al
aspect
relat
zoonosi
fig
multipl
cycl
caliciviru
replic
caliciviru
schemat
subdivid
eleven
step
attach
protein
core
cellular
receptor
virion
intern
cell
step
uncoat
viral
genom
step
follow
translat
polyprotein
precursor
step
cotransl
process
releas
nonstructur
protein
step
protein
assembl
replic
complex
step
synthes
antigenom
rna
step
use
templat
synthesi
genom
rna
step
newli
synthes
genom
rna
translat
polyprotein
precursor
step
use
packag
assembl
viral
protein
core
step
antigenom
rna
also
templat
synthesi
subgenom
rna
step
norovirus
vesivirus
possibl
recovirus
subgenom
rna
translat
structur
protein
step
sapovirus
lagovirus
possibl
beconabovirus
releas
polyprotein
precursor
process
viral
proteas
still
defin
time
multipl
cycl
assembl
structur
protein
well
packag
genom
rna
occur
step
follow
releas
matur
virion
cell
step
sinc
norovirus
sapovirus
includ
strain
human
nonhuman
pathogen
high
preval
antibodi
bind
noroviru
sapoviru
neutral
tulan
viru
recent
detect
captiv
juvenil
macaqu
farka
et
al
addit
sera
collect
noroviru
outbreak
patient
display
neutral
effect
tulan
viru
infect
vitro
farka
et
al
data
although
preliminari
may
indic
possibl
crossspeci
transmiss
human
andor
nonhuman
pathogen
caliciviru
although
crossreact
sera
exclud
moreov
crossspeci
transmiss
bovin
noroviru
strain
recent
invalid
fact
carbohydr
ligand
requir
attach
viru
absent
human
tissu
zakhour
et
al
experiment
epidemiolog
data
gener
far
strongli
favor
crossspeci
transmiss
transmiss
hucv
occur
via
fecalor
rout
viru
transmit
via
aerosol
observ
explos
vomit
koopman
koopman
duizer
environment
resist
hucv
combin
high
infect
infecti
dose
viral
particl
facilit
effici
transmiss
human
suscept
infect
norovirus
also
depend
blood
group
individu
b
histoblood
group
antigen
hbga
one
recogn
bind
receptor
norovirus
hennessi
et
al
hutson
et
al
lindesmith
et
al
marionneau
et
al
rockx
et
al
hbga
present
surfac
erythrocyt
mucos
epitheli
cell
free
oligosaccharid
milk
saliva
gut
fluid
marionneau
et
al
recent
studi
underli
differ
hbga
present
saliva
milk
human
milk
hbga
synthes
higher
quantiti
display
smaller
molecular
weight
differ
backbon
although
hbga
high
molecular
weight
may
also
found
huang
et
al
variabl
hbga
content
natur
seem
play
import
role
modul
specif
bind
human
pathogen
noroviru
hbga
present
saliva
andor
milk
subsequ
transmiss
bind
protein
hbga
shown
occur
subdomain
cao
et
al
tan
et
al
tan
et
al
differenti
bind
subdomain
hbga
induc
differenti
suscept
human
infect
differ
noroviru
genogroup
bind
subdomain
modul
phenotyp
fucosyltransferas
fut
enzym
fucosyltransferas
fut
conjug
fucosyl
residu
nacetylglucosamin
hbga
individu
lack
function
enzym
call
nonsecretor
secret
abo
hbga
saliva
gut
fluid
individu
harbor
function
enzym
call
secretor
display
b
lewi
b
phenotyp
relat
express
enzym
b
type
conjug
precursor
h
type
hbga
glucosyl
residu
enzym
fucosyl
residu
nonsecretor
lewi
resist
infect
major
noroviru
stain
nonsecretor
phenotyp
present
european
north
american
popul
marionneau
et
al
howev
kept
mind
neither
sapoviru
genogroup
sapoviru
gv
viruslik
particl
display
bind
abo
hbga
shiratohorikoshi
et
al
indic
differ
cellular
receptor
possibl
mechan
intern
norovirus
sapovirus
base
knowledg
caliciviru
genom
organ
molecular
biolog
transmiss
replic
potenti
antivir
strategi
least
conceiv
follow
section
describ
potenti
caliciviru
target
drug
develop
possibl
antivir
approach
use
experiment
data
structur
function
viral
enzym
replic
gener
success
collabor
within
european
consortium
vizier
also
present
first
step
viral
infect
attach
virion
cell
surfac
interact
specif
receptor
lead
intern
follow
uncoat
viral
genom
releas
cytoplasm
inhibit
viral
infect
cell
may
therefor
possibl
inhibit
bind
virion
andor
intern
andor
releas
viral
genom
recent
work
felin
caliciviru
identifi
specif
receptor
intern
virion
makino
et
al
fcv
attach
sialic
acid
use
junction
adhes
molecul
member
immunoglobulin
superfamili
intern
crandellre
felin
kidney
crfk
cell
express
tight
junction
varieti
cell
anti
antibodi
reduc
fcv
bind
crfk
cell
thu
reduc
infecti
viru
yield
makino
et
al
advanc
character
specif
receptor
may
repres
interest
antivir
approach
target
caliciviru
receptor
ie
use
appropri
monoclon
antibodi
howev
consid
broad
divers
host
cell
enter
cell
respiratori
epithelium
dendrit
cell
neuron
cell
import
hurdl
remain
instanc
murin
noroviru
recent
report
bind
gangliosid
present
surfac
murin
macrophag
taub
et
al
gangliosid
thought
mediat
attach
intern
probabl
requir
addit
factor
exampl
integrin
recent
studi
report
involv
cholesterol
depend
pathway
entri
murin
noroviru
cell
clathrin
caveola
pathway
requir
cell
entri
gerondopoulo
et
al
whether
phenotyp
common
norovirus
unclear
also
unknown
whether
involv
alon
bind
virion
membran
protein
interact
case
inhibit
bind
one
receptor
may
lead
inhibit
viral
entri
cell
mechan
steric
alloster
blockad
interact
viru
receptor
still
littl
known
intern
receptor
lagovirus
sapovirus
attach
hucv
abo
hbga
heparan
sulfat
sialyllewi
x
rydel
et
al
tamura
et
al
demonstr
vitro
use
viruslik
particl
vlp
lack
cell
cultur
system
reproduc
human
pathogen
caliciviru
imped
work
subject
area
interest
antivir
approach
may
block
interact
noroviru
hbga
recent
studi
feng
jiang
feng
et
al
screen
compound
librari
use
salivabas
receptor
bind
assay
block
interact
secret
hbga
vlp
noroviru
strain
vlp
display
similar
antigen
properti
nativ
virion
use
tool
investig
virushost
interact
immun
respons
anim
model
screen
potenti
antinoroviru
candid
green
et
al
huang
et
al
huang
et
al
jiang
et
al
compound
screen
ec
valu
less
found
compound
ec
hucv
thought
replic
intestin
cell
inhibit
attach
hucv
hbga
receptor
may
repres
interest
strategi
inhibit
infect
cell
appli
earli
cours
infect
may
also
block
propag
virion
within
tissu
kind
treatment
may
suitabl
prevent
setup
cours
spatial
limit
outbreak
occur
exampl
cruis
ship
similar
approach
reli
trap
noroviru
glycosyl
hydrogel
zhang
et
al
trap
capac
hydrogel
estim
g
vlp
per
mg
although
promis
approach
suitabl
prevent
transmiss
noroviru
persontoperson
contrast
norovirus
human
pathogen
sapovirus
reli
attach
hbga
addit
data
concern
viru
bind
entri
need
bring
proofofprincipl
attachmentinhibitionbas
antivir
approach
calicivirus
mani
virus
enter
cell
cytoplasm
endocyt
vesicl
pelkman
heleniu
smith
heleniu
mammalian
cell
variou
endocytosi
pathway
describ
macropinocytosi
phagocytosi
endocytosi
via
caveolaelipid
raft
clathrinmedi
endocytosi
follow
endocytosi
uncoat
viral
genom
may
depend
lower
ph
endocyt
vesicl
ph
chang
lead
conform
chang
viral
capsid
exposit
motiv
locat
subdomain
bhella
et
al
experiment
setup
low
phenviron
endosom
induc
structur
chang
fcv
capsid
lead
releas
viral
genom
rna
stuart
brown
henc
possibl
antivir
approach
may
use
compound
short
peptid
inhibit
rearrang
viral
surfac
relat
ph
chang
anoth
approach
may
reli
induc
phmodif
differ
compart
cell
subsequ
intracellular
phgradient
two
differ
compound
known
inhibit
reduct
endosom
ph
weak
basic
compound
chloroquin
macrolid
antibiot
select
inhibit
vacuolar
type
vesicular
proton
atpas
bafilomycin
bafilomycin
chloroquin
increas
concentrationdepend
manner
ph
endosom
compart
may
use
inhibit
uncoat
viral
genom
inhibit
acidif
endosom
interestingli
chloroquin
bafilomycin
inhibit
fcv
infect
vitro
stuart
brown
moreov
chlorpromazin
compound
known
inhibit
clathrinmedi
endocytosi
inhibit
intern
fcv
vitro
stuart
brown
remain
unclear
whether
calicivirus
display
similar
entri
uncoat
mechan
recent
data
murin
noroviru
reveal
infect
murin
inhibit
reagent
rais
endosom
ph
gerondopoulo
et
al
nevertheless
three
substanc
commerci
avail
repres
promis
approach
control
infect
fcv
releas
cytoplasm
viral
mrna
recruit
endoplasm
reticulum
translat
produc
viral
polyprotein
stage
inhibit
function
whole
genom
rna
andor
part
stop
viral
replic
end
two
strategi
develop
calicivirida
make
use
nucleic
acid
target
end
andor
end
genom
compar
analysi
structur
featur
member
calicivirida
shown
strain
display
stemloop
hairpin
structur
terminu
viral
genom
respect
simmond
et
al
use
experiment
approach
base
murin
noroviru
revers
genet
system
disrupt
stem
loop
strongli
impair
viral
replic
murin
macrophag
vitro
simmond
et
al
moreov
polypyrimidin
tract
locat
terminu
genom
incrimin
regul
viral
fit
virul
small
anim
model
infect
bailey
et
al
indic
structur
play
import
role
infect
mnv
region
preferenti
target
nucleic
acid
base
approach
bear
highli
conserv
sequenc
within
genera
ie
fcv
tabl
nucleic
acidbas
strategi
antisens
approach
posttranscript
gene
silenc
rnainterfer
approach
import
prerequisit
success
implement
nucleic
acidbas
antivir
approach
first
target
sequenc
involv
viral
replic
addit
must
access
oligonucleotid
hybrid
importantli
deal
rna
virus
high
genom
variabl
must
conserv
among
differ
viral
speci
henc
region
preferenti
target
resid
within
utr
viral
genom
conserv
region
may
span
entir
genera
antisens
approach
use
dnaoligonucleotid
target
conserv
region
viral
genom
appli
variou
model
viral
infect
positivestrand
negativestrand
rna
virus
gabriel
et
al
lupfer
et
al
paessler
et
al
stein
stein
shi
calicivirida
peptidelink
phosphorodiamidi
morpholino
oligom
ppmo
target
sequenc
near
utr
murin
noroviru
genom
effect
reduc
translat
viral
protein
vitro
bok
et
al
preliminari
investig
made
use
ppmoapproach
inhibit
multipl
felin
caliciviru
vitro
seven
ppmo
kindli
provid
dr
david
stein
avi
biopharma
design
target
viral
genom
particular
utr
utr
felin
caliciviru
genom
tabl
cell
prolifer
assay
lowest
ec
observ
select
index
tabl
phosphorodiamidi
morpholino
oligom
pmo
target
utr
fcv
genom
use
clinic
trial
relat
fcv
outbreak
day
infect
pmo
administ
parenter
kitten
day
differ
dosag
mgkg
pmo
display
dosedepend
effect
anim
treat
surviv
infect
comparison
anim
treat
pmo
surviv
infect
tabl
antivir
activ
cell
toxic
oligonucleotid
use
nucleic
acid
base
approach
valu
measur
colorimetr
cellprolifer
assay
describ
other
oxford
et
al
although
preliminari
experiment
data
indic
ppmo
may
repres
interest
approach
treatment
caliciviru
infect
anoth
approach
target
viral
genom
posttranscript
silenc
use
sequenc
specif
rnainterfer
use
rna
interfer
silenc
exogen
rna
viral
genom
rna
extens
report
haasnoot
et
al
differ
approach
use
sirna
employ
viral
infect
model
vivo
vitro
bitko
barik
boden
et
al
von
eij
et
al
ge
et
al
ge
et
al
tompkin
et
al
zhang
et
al
bitko
et
al
major
problem
rnaiapproach
resid
design
sirna
deliveri
molecul
target
cell
furthermor
cellular
compart
target
rna
locat
anoth
problem
relat
stabil
sirna
well
bioavail
li
et
al
problem
relat
offtarget
effect
observ
seed
sequenc
sirna
crossreact
host
cellular
mrna
jackson
et
al
lin
et
al
nevertheless
one
major
advantag
rnaibas
strategi
faster
effici
develop
lead
compound
compar
classic
small
molecul
particularli
interest
rna
virus
high
genom
variabl
calicivirida
particularli
human
pathogen
noroviru
inde
case
emerg
pandem
new
noroviru
variant
rapid
optim
sirna
molecul
may
facilit
acceler
design
synthesi
rnaicompound
thu
control
infect
moreov
judici
design
rnaimolecul
well
correct
choic
target
sequenc
broadspectrum
activ
antivir
achiev
calicivirida
conserv
sequenc
interest
exampl
two
sirna
target
conserv
sequenc
utr
utr
respect
use
sirna
nm
transfect
crfk
cell
h
prior
infect
fcv
plaqu
assay
perform
describ
other
gray
yield
viral
titr
pfuml
sirna
complet
inhibit
viral
multipl
crfk
cell
specif
region
within
utr
fcv
howev
region
may
problemat
bind
cellular
translat
product
potenti
antivir
molecul
possibl
caus
steric
block
sirna
observ
small
molecul
administr
sirna
may
also
induc
emerg
resist
mutant
therefor
anoth
strategi
would
target
cellular
factor
indispens
viral
replic
dispens
cellular
metabol
preliminari
setup
use
small
interf
rna
molecul
target
utr
subgenom
region
fcv
genom
strain
genbank
access
prophylaxi
model
infect
crfk
cell
transfect
sirna
follow
infect
cell
sirna
complet
inhibit
viral
multipl
fig
cell
prolifer
assay
ec
nm
lower
ec
observ
ppmo
target
sequenc
tabl
although
provision
data
suggest
posttranscript
gene
silenc
may
potenti
antivir
approach
target
viral
genom
summari
comparison
small
molecul
nucleicacid
base
approach
offer
mani
advantag
may
render
attract
antivir
strategi
strength
reli
select
possibl
rapid
optim
lead
compound
particular
case
emerg
virus
high
genom
variabl
nevertheless
sever
prerequisit
fulfil
implement
therapeut
tool
clearli
two
major
hurdl
would
bioavail
specif
deliveri
infect
cell
translat
viral
genom
first
step
replic
cycl
positivesens
rna
virus
initi
translat
report
depend
interact
vpg
cellular
translat
factor
initi
complex
complex
key
player
initi
translat
eukaryot
mrna
assembl
preiniti
complex
mrna
via
interact
capstructur
gingra
et
al
kapp
lorsch
complex
consist
rna
helicas
factor
directli
interact
capstructur
mrna
bind
protein
cellular
translat
modul
poli
bind
protein
pabp
fcv
mnv
vpg
interact
initi
factor
wherea
vpg
nv
interact
goodfellow
et
al
fcv
mnv
translat
polyprotein
precursor
depend
presenc
function
compon
complex
rna
helicas
inde
treatment
fcv
infect
cell
small
molecul
inhibitor
hippuristanol
block
translat
viral
protein
hippuristanol
interact
cterminu
subsequ
inhibit
ntpase
henc
helicas
activ
bordeleau
et
al
importantli
hippuristanol
expect
toxic
effect
cell
due
inhibit
host
cell
well
caliciviru
protein
synthesi
similar
way
pateamin
stimul
helicas
ntpase
activ
dysregul
function
within
translat
complex
bordeleau
et
al
sens
use
inhibitor
compon
complex
ie
hippuristanol
bordeleau
et
al
dysregul
function
ie
pateamin
low
et
al
promis
approach
anoth
import
regul
translat
interact
untransl
region
viral
genom
cellular
host
factor
involv
protein
translat
end
caliciviru
genom
untransl
region
utr
variabl
size
genogroup
genera
present
although
experiment
evid
direct
interact
structur
translat
machineri
still
lack
disrupt
structur
model
infect
vitro
led
strong
impair
replic
murin
noroviru
data
support
concept
import
role
structur
termini
caliciviru
genom
viral
multipl
cycl
properti
caliciviru
genom
highli
structur
common
amongst
mani
positivestrand
rna
virus
goodfellow
et
al
haasnoot
et
al
picornavirus
ie
creelement
goodfellow
et
al
ire
pelleti
sonenberg
xiang
et
al
flavivirus
tsukiyamakohara
et
al
wang
et
al
gould
b
proutski
et
al
proutski
et
al
b
utr
viral
genom
highli
structur
sequenc
fold
function
conform
order
ensur
appropri
fold
subsequ
interact
viral
structur
nonstructur
protein
cellular
chaperon
polypyrimidin
tractbind
protein
ptb
requir
herschlag
treiber
williamson
ptb
express
nucleu
cytoplasm
act
regul
splice
pathway
ghetti
et
al
lin
patton
ptb
postul
work
chaperon
viral
genom
rna
implic
fold
secondari
structur
locat
terminu
genom
fcv
ptb
interact
specif
sequenc
locat
utr
genom
karakasilioti
et
al
requir
multipl
fcv
host
cell
murin
noroviru
ptb
bind
polypyrimidin
tract
locat
within
utr
viral
genom
bailey
et
al
interact
report
essenti
viru
replic
although
import
regul
viral
fit
virul
bailey
et
al
host
cell
factor
unr
boussadia
et
al
poli
rc
bind
protein
pcbp
parsley
et
al
la
autoantigen
meerovitch
et
al
hnrnp
huang
lai
poli
bind
protein
pabp
interact
viral
genom
varieti
rna
virus
host
cellular
factor
modul
translat
process
viral
polyprotein
also
translat
host
cell
mrna
human
pathogen
norwalk
viru
ptb
gutierrezescolano
et
al
la
autoantigen
hnrnp
interact
utr
utr
la
ptb
gutierrezescolano
et
al
although
function
role
protein
noroviru
replic
describ
far
taken
togeth
knowledg
translat
initi
calicivirida
offer
interest
possibl
ie
peptid
nucleic
acid
target
interact
viral
genom
andor
vpg
cellular
host
factor
translat
subsequ
inhibit
viral
protein
synthesi
caliciviru
chymotrypsinlik
proteas
play
central
role
viral
replic
molecular
mechan
underli
catalyt
activ
specif
noroviru
sapoviru
murin
noroviru
felin
caliciviru
proteas
extens
investig
knowledg
regul
caliciviru
polyprotein
process
import
prerequisit
develop
antivir
drug
control
caliciviru
infect
viral
proteas
involv
earli
step
replic
activ
form
viral
protein
pro
protein
precursor
consist
viral
proteas
polymeras
pro
pol
cleavag
pattern
caliciviru
polyprotein
precursor
viral
proteas
investig
cellfre
express
system
liu
et
al
seah
et
al
mammalian
cell
seah
et
al
seah
et
al
sosnovtsev
et
al
process
human
norwalk
viru
cell
murin
noroviru
strain
macrophagelik
cell
line
shown
pro
pol
precursor
pro
present
infect
cell
similar
observ
report
relat
nonhuman
pathogen
caliciviru
strain
rabbit
hemorrhag
diseas
viru
rhdv
genu
lagoviru
howev
anoth
human
pathogen
caliciviru
sapoviru
sv
pro
pol
protein
detect
cellfre
system
oka
et
al
b
case
pathogen
felin
caliciviru
fcv
pro
pol
precursor
detect
mammalian
cell
sosnovtsev
et
al
sosnovtsev
et
al
sosnovtseva
et
al
accord
observ
scheffler
et
al
evid
autocatalyt
cleavag
noroviru
pro
polyprotein
precursor
present
liu
et
al
seah
et
al
sosnovtsev
et
al
cleavag
specif
effici
noroviru
sapoviru
pro
pro
pol
examin
vitro
use
peptid
bear
cleavag
site
polyprotein
noroviru
glngli
requir
posit
frame
scissil
bond
peptid
cleav
proteas
sapoviru
cleavag
specif
effici
seem
modul
posit
scissil
bond
cleavag
specif
observ
explain
studi
structur
noroviru
proteas
nakamura
et
al
zeitler
et
al
sapoviru
proteas
robel
et
al
sapoviru
pro
catalyt
triad
consist
cy
glu
locat
bottom
pocket
role
interact
side
chain
substrat
observ
noroviru
pro
see
anoth
residu
play
import
role
hold
glu
proper
posit
triad
featur
exist
noroviru
proteas
crystal
structur
noroviru
pro
reveal
five
residu
govern
specif
substrat
bind
proteas
ala
pocket
ile
arg
val
pocket
nakamura
et
al
pocket
residu
interact
gln
residu
scissil
bond
zeitler
et
al
import
substrat
bind
sinc
mutat
sever
reduc
activ
pro
someya
et
al
rna
virus
human
rhinoviru
hepat
viru
polioviru
coronaviru
similar
observ
made
site
interact
imidazol
ring
carboxamid
chain
residu
allair
et
al
anand
et
al
anand
et
al
bergmann
et
al
matthew
et
al
mosimann
et
al
yang
et
al
furthermor
presenc
small
residu
gli
ala
posit
scissil
bond
noroviru
polyprotein
consist
limit
volum
allow
residu
pocket
noroviru
proteas
nakamura
et
al
contrast
hydrophob
pocket
noroviru
proteas
larg
enough
accommod
side
chain
bulki
hydrophob
amino
acid
phe
met
leu
nakamura
et
al
similarli
bind
site
residu
noroviru
pro
report
larg
enough
accommod
residu
variou
size
ie
ser
gli
thr
pocket
phe
met
ala
leu
pocket
nakamura
et
al
specif
cleavag
scissil
bond
polyprotein
variou
caliciviru
genera
peptidomimet
substratelik
peptid
may
constitut
interest
strategi
inhibit
viral
replic
anoth
possibl
approach
may
use
inhibitor
block
proteas
activ
site
implement
approach
least
two
import
barrier
cross
larg
size
peptid
compound
possibl
poor
bioavail
ii
limit
vivo
stabil
peptid
nevertheless
extens
knowledg
gener
structur
function
chymotrypsinlik
proteas
target
viral
proteas
may
one
promis
approach
inhibit
caliciviru
replic
rdrp
involv
synthesi
genom
subgenom
antigenom
rna
caliciviru
structur
analysi
noroviru
sapoviru
rhdv
rdrp
reveal
righthand
structur
typic
templatedepend
polymeras
biswal
et
al
choi
et
al
ferrerorta
et
al
ng
et
al
ng
et
al
interestingli
structur
similar
exist
shorten
loop
section
rhdv
sapoviru
noroviru
pol
ng
et
al
suggest
similar
mechan
activ
rna
elong
calicivirida
nevertheless
sapoviru
pol
display
function
similar
noroviru
pol
vesiviru
fcv
lagoviru
rhdv
rdrp
relat
mainli
abil
sapoviru
noroviru
pol
initi
rna
synthesi
de
novo
heteropolymer
templat
primerdepend
initi
rna
synthesi
homopolymer
templat
termin
transferas
activ
prefer
ctp
rohayem
et
al
fullerton
et
al
potenti
strategi
inhibit
caliciviru
rdrp
fall
two
categori
nucleosid
analogu
inhibitor
nonnucleosid
inhibitor
fig
inhibit
activ
noroviru
sapoviru
rnadepend
rna
polymeras
nucleosid
analogu
assess
activ
noroviru
rnadepend
rna
polymeras
determin
previous
describ
rohayem
et
al
b
b
assess
activ
sapoviru
rnadepend
rna
polymeras
pol
determin
previous
describ
fullerton
et
al
nucleosid
analog
display
similar
mechan
inhibit
rdrp
activ
nucleosid
penetr
cell
undergo
phosphoryl
triphosph
give
nucleotid
incorpor
polymer
nucleic
acid
chain
elong
rdrp
lead
chain
termin
preliminari
investig
order
valid
polymeras
hucv
target
antivir
design
test
five
differ
nucleosid
analog
potenti
inhibitor
activ
hucv
polymeras
shown
fig
triphosph
trilink
technolog
triphosph
trilink
technolog
display
potent
inhibitor
activ
hucv
polymeras
concentr
contrast
nucleosid
analog
show
activ
hucv
polymeras
provision
data
favor
use
hucv
rnadepend
rna
polymeras
target
develop
antivir
drug
fig
anoth
substanc
interest
ribavirin
ribavirin
effici
inhibit
noroviru
replic
vitro
chang
georg
ribavirin
synthet
guanosin
analogu
broad
rang
antivir
activ
rna
also
dna
virus
nv
replicon
system
ribavirin
report
display
ec
chang
georg
valu
mnvinfect
cell
treat
chang
georg
felin
caliciviru
ribavirin
howev
effect
vivo
povey
b
although
experiment
data
vitro
encourag
ribavirin
lot
advers
effect
narrow
therapeut
index
time
point
suitabl
treatment
diseas
viral
gastroenter
almost
lethal
outcom
vpg
put
link
genom
rna
calicivirus
although
experiment
evid
linkag
still
lack
nonhuman
pathogen
calicivirus
vpg
involv
uridylyl
proteinprim
depend
initi
rna
synthesi
antigenom
presum
genom
rna
uridylyl
thought
occur
tyrosin
protein
shown
mutat
analysi
fcv
revers
genet
system
mitra
et
al
uridylyl
experiment
proven
norovirus
belliot
et
al
rohayem
et
al
lagovirus
machin
et
al
uridylyl
thought
involv
viral
rdrp
vpg
well
polyadenyl
viral
genom
whether
antigenom
viral
rna
involv
remain
unknown
analog
polioviru
could
potenti
prevent
uridylyl
viral
genom
could
also
interest
antivir
approach
inhibit
interact
vpg
rdrp
andor
viral
genom
result
shutoff
synthesi
viral
genom
rna
anoth
possibl
target
antivir
therapi
caliciviru
ntpase
ntpase
display
canon
motiv
viral
ntpase
describ
picornavirus
flavivirus
instanc
occurr
three
motiv
gxxgxgkst
b
dde
c
kxxxfxsxxxxxsttn
classifi
caliciviru
ntpase
superfamili
rna
helicas
pfister
wimmer
although
experiment
evid
vitro
cell
cultur
put
rna
unwind
activ
still
lack
recombin
ntpase
display
ntpase
activ
vitro
bind
rna
unwind
rnarna
rnadnaduplex
pfister
wimmer
futur
experiment
evid
may
help
design
innov
antivir
strategi
target
import
enzym
caliciviru
replic
analog
flaviviru
ntpasehelicas
extens
studi
character
function
structur
inhibitor
ntpasehelicas
may
act
competit
inhibit
blockad
ntp
bind
site
ii
conform
chang
immobil
switch
region
iii
competit
inhibit
rna
bind
iv
inhibit
unwind
via
steric
blockad
transloc
ntpasehelicas
along
templat
rna
viral
enzym
replic
interact
complex
multipl
compon
constitut
replic
complex
complex
may
transient
rel
stabl
abil
viral
enzym
interact
one
partner
interest
may
significantli
influenc
complex
member
calicivirus
replic
complex
predict
involv
mainli
three
viral
enzym
rnadepend
rna
polymeras
viral
proteas
ntpasehelicas
addit
viral
genomicantigenom
andor
subgenomicantisubgenom
rna
structur
viral
protein
may
includ
also
vpg
ntermin
protein
experiment
data
use
norovirus
shown
ntermin
protein
interact
vesicular
complex
vapaprotein
vesicleassoci
membran
proteinassoci
protein
lead
inhibit
intracellular
protein
traffick
ettayebi
hardi
fcv
interact
ntpase
vpg
propol
demonstr
vitro
kaiser
et
al
fcv
propol
also
report
interact
vpg
interact
structur
protein
kaiser
et
al
far
determin
assembl
structur
replic
complex
well
role
regul
life
cycl
viru
remain
poorli
understood
moreov
recent
result
gener
within
vizierconsortium
indic
small
molecul
inhibit
viral
replic
mammalian
cell
might
possibl
target
replic
complex
specif
interact
viral
enzym
within
complex
effect
small
molecul
would
mainli
destabil
complex
subsequ
inhibit
replic
viral
genom
henc
multipl
viru
within
cell
therefor
knowledg
function
structur
determin
interact
assembl
replic
complex
could
provid
cornerston
develop
new
antivir
strategi
work
within
vizierconsortium
contribut
deciph
activ
noroviru
rdrp
show
activ
form
viral
rdrp
norovirus
homodim
display
posit
cooper
hogbom
et
al
result
also
show
homodimer
noroviru
monom
concentrationdepend
appar
k
homodimer
lie
within
nm
rang
moreov
monom
display
posit
cooper
vitro
similar
observ
propol
fcv
cultiv
cell
system
report
kaiser
et
al
develop
antivir
strategi
aim
destabil
interact
pol
monom
interest
anoth
approach
may
reli
target
interact
structur
protein
within
replic
complex
follow
replic
viral
genom
step
assembl
capsid
protein
bud
virion
endoplasm
reticulum
transport
matur
virion
er
golgi
complex
vesicl
fusion
lead
releas
matur
virion
recent
experiment
data
felin
caliciviru
shown
upon
infect
viral
nonstructur
protein
coloc
er
lead
morpholog
chang
er
membran
bailey
et
al
remain
howev
unclear
whether
rearrang
incrimin
assembl
replic
complex
calicivirus
step
poorli
understood
therefor
antivir
strategi
target
postrepl
step
genom
develop
substanti
knowledg
step
gener
immun
human
pathogen
calicivirus
poorli
understood
mainli
lack
cell
cultur
system
investig
neutral
viru
multipl
serum
intestin
secretori
antibodi
howev
volunt
challeng
studi
establish
human
pathogen
calicivirus
particularli
norovirus
induc
two
form
immun
shortterm
longterm
immun
atmar
et
al
parrino
et
al
wyatt
et
al
shortterm
immun
virusspecif
individu
infect
noroviru
strain
resist
reinfect
strain
week
follow
primari
infect
longterm
immun
contrast
confer
resist
infect
last
month
follow
primari
infect
anoth
interest
aspect
relat
type
cellmedi
immun
follow
infect
human
pathogen
caliciviru
ie
noroviru
volunt
challeng
studi
shown
cellmedi
immun
respons
noroviru
infect
display
domin
pattern
lindesmith
et
al
anim
model
import
insight
noroviru
immun
infect
well
pathogenesi
gener
recent
base
surrog
mnv
bailey
et
al
mccartney
et
al
mumphrey
et
al
viruslik
particl
mimic
structur
antigen
nativ
capsid
protein
extens
use
explor
function
reactiv
norovirus
sapovirus
guo
et
al
hansman
et
al
hansman
et
al
jiang
et
al
oka
et
al
vlp
produc
rel
high
yield
baculoviru
recombin
express
system
human
endotheli
kidney
cell
line
taub
et
al
assembl
absenc
although
seem
enhanc
vlp
stabil
green
et
al
jiang
et
al
furthermor
feed
volunt
laboratori
anim
noroviru
viruslik
particl
gener
tomato
plant
huang
et
al
potato
plant
tacket
et
al
led
immun
respons
igg
iga
variabl
intens
depend
adjuv
use
previou
data
vaccin
guerrero
et
al
ball
et
al
control
infect
human
calicivirus
encourag
deserv
develop
evalu
fcv
vaccin
avail
develop
effici
vaccin
possibl
fcv
amplifi
crfk
cell
small
model
felin
also
avail
fcv
vaccin
use
either
attenu
inactiv
viru
furthermor
dualstrain
fcv
vaccin
consist
virul
attenu
strain
alreadi
success
implement
clinic
trial
huang
et
al
vlp
also
effect
gener
neutral
antibodi
rabbit
variou
fcv
strain
indic
could
repres
interest
altern
attenu
inactiv
virus
product
fcv
vaccin
di
martino
et
al
recent
studi
lobu
et
al
multival
noroviru
vlp
adjuv
alphaviru
cpg
dna
administr
mice
vlp
induc
mucos
system
immun
respons
reduct
viral
titer
immun
mice
follow
mnv
challeng
sera
immun
mice
prove
protect
mnv
transfer
immunodefici
mice
similarli
vlp
repres
rhdv
bear
cell
epitop
ovalbumin
shown
abl
elicit
cell
immun
respons
dendrit
cell
induc
cellular
immun
respons
mice
crisci
et
al
data
encourag
highlight
potenti
vlpbase
approach
develop
caliciviru
vaccin
anoth
experiment
approach
base
inhibit
noroviru
replic
interferon
use
revers
genet
system
nv
chang
georg
shown
inhibit
translat
replic
caliciviru
dosedepend
manner
vitro
correl
suscept
mnv
ifn
observ
vitro
changotra
et
al
wobu
et
al
also
vivo
karst
et
al
although
observ
ec
micromolar
rang
data
interest
context
antivir
effect
ifn
calicivirus
gener
approach
treatment
human
pathogen
caliciviru
infect
reli
substitut
electrolyt
water
loss
per
os
per
enter
rehydr
repres
henc
symptomat
treatment
infect
anderson
antivir
approach
posit
effect
nitazoxanid
control
noroviru
infect
also
describ
rossignol
elgohari
possibl
cultiv
member
three
genera
norovirus
vesivirus
recovirus
within
famili
calicivirida
import
step
toward
better
understand
replic
cycl
virus
also
develop
effect
antivir
strategi
nevertheless
clearli
need
cultur
system
propag
human
pathogen
variant
norovirus
sapovirus
mammalian
cell
hamper
develop
antivir
approach
well
vaccin
also
indepth
studi
pathogen
human
pathogen
caliciviru
account
slow
progress
field
one
potenti
problem
caus
treatment
caliciviru
infect
observ
rna
virus
posit
strand
genom
emerg
drug
resist
major
problem
lie
high
genom
variabl
strain
particular
human
pathogen
norovirus
well
acceler
emerg
new
variant
therefor
antivir
strategi
aim
target
conserv
region
viral
genom
possibl
expos
immunolog
pressur
lead
immun
escap
short
durat
diseas
treatment
caliciviru
infect
may
focu
contain
infect
context
outbreak
well
longterm
shed
virion
infect
observ
follow
infect
norovirus
